Mandatum Life Insurance Co Ltd Buys Shares of 4,600 Lemonade, Inc. $LMND

Key Points

• Mandatum Life Insurance Co Ltd has acquired a new stake of 4,600 shares in Lemonade, Inc., valued at approximately $202,000 during Q2.
• Lemonade's stock has seen significant institutional activity, with major hedge funds raising their positions, indicating a growing interest in the company.
• Despite reporting a negative EPS of ($0.60), Lemonade's revenue increased by 34.5% year-over-year, suggesting potential for future growth.

Mandatum Life Insurance Co Ltd acquired a new stake in shares of Lemonade, Inc. (NYSE:LMND - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,600 shares of the company's stock, valued at approximately $202,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. SVB Wealth LLC bought a new stake in shares of Lemonade during the first quarter valued at about $26,000. NewEdge Advisors LLC bought a new stake in shares of Lemonade during the first quarter valued at about $35,000. Hollencrest Capital Management bought a new stake in Lemonade in the first quarter worth about $41,000. State of Wyoming bought a new stake in Lemonade in the first quarter worth about $49,000. Finally, US Bancorp DE raised its position in Lemonade by 28.3% in the first quarter. US Bancorp DE now owns 2,406 shares of the company's stock worth $76,000 after acquiring an additional 531 shares in the last quarter. 80.30% of the stock is currently owned by institutional investors.

Lemonade Price Performance

NYSE LMND traded up $1.61 on Tuesday, hitting $61.29. 1,084,727 shares of the company were exchanged, compared to its average volume of 2,326,863. The company's 50 day moving average price is $49.61 and its 200-day moving average price is $39.61. The firm has a market capitalization of $4.53 billion, a P/E ratio of -21.60 and a beta of 2.27. Lemonade, Inc. has a twelve month low of $15.27 and a twelve month high of $61.82.

Lemonade (NYSE:LMND - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.81) by $0.21. The firm had revenue of $164.10 million for the quarter, compared to the consensus estimate of $160.88 million. Lemonade had a negative return on equity of 36.12% and a negative net margin of 33.96%.The business's revenue for the quarter was up 34.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.81) EPS. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts expect that Lemonade, Inc. will post -3.03 EPS for the current year.

Insider Activity

In other Lemonade news, insider John Sheldon Peters sold 2,718 shares of Lemonade stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $50.34, for a total transaction of $136,824.12. Following the transaction, the insider owned 102,397 shares of the company's stock, valued at $5,154,664.98. The trade was a 2.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Adina Eckstein sold 5,000 shares of Lemonade stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $49.00, for a total value of $245,000.00. Following the transaction, the chief operating officer directly owned 189,653 shares in the company, valued at approximately $9,292,997. This trade represents a 2.57% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,000 shares of company stock worth $396,020. Corporate insiders own 12.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on LMND shares. Cantor Fitzgerald upgraded shares of Lemonade to a "strong-buy" rating in a research report on Wednesday, August 13th. Morgan Stanley reiterated an "underweight" rating on shares of Lemonade in a research report on Monday, August 18th. Piper Sandler boosted their price target on shares of Lemonade from $55.00 to $60.00 and gave the stock a "neutral" rating in a research report on Wednesday, September 17th. Keefe, Bruyette & Woods reiterated an "underperform" rating and issued a $26.00 price target (up from $22.00) on shares of Lemonade in a research report on Tuesday, July 1st. Finally, BMO Capital Markets boosted their price target on shares of Lemonade from $23.00 to $42.00 and gave the stock an "underperform" rating in a research report on Monday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has assigned a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $41.14.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.